Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine

An Aspergillus fumigatus vaccine based on recombinant Asp f3-protein has the potential to prevent aspergillosis in humans, a devastating fungal disease that is the prime obstacle to the success of hematopoietic cell transplantation. This vaccine protects cortisone acetate (CA)-immunosuppressed mice...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz-Arevalo, Diana, Ito, James I., Kalkum, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441197/
https://www.ncbi.nlm.nih.gov/pubmed/23024640
http://dx.doi.org/10.3389/fmicb.2012.00299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441197/
https://www.ncbi.nlm.nih.gov/pubmed/23024640
http://dx.doi.org/10.3389/fmicb.2012.00299

Ejemplares similares